QLIFE HOLDING AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0012 SEK | +9.09% |
|
-29.41% | -93.97% |
| 07-02 | Qlife Participates Research Trial for People Living with PKU and Gets Positive Data | CI |
| 06-03 | Qlife Starts Clinical Trial in China with First Biomarker on Egoo Health | CI |
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Calendar
14/08/2024
- Q2 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -93.97% | 379K | |
| -6.24% | 180B | |
| -6.08% | 98.89B | |
| -5.98% | 66.26B | |
| -9.35% | 44.61B | |
| +8.34% | 44.02B | |
| +10.13% | 40.12B | |
| +11.88% | 29.19B | |
| -8.38% | 23.64B | |
| +13.33% | 23.41B |
- Stock Market
- Equities
- QLIFE Stock
- News Qlife Holding AB
- Qlife Plans Layoffs, Cost Reductions; Shares Down 11%
